SE Howlett - Cardiovascular Research, 2011 - cardiovascres.oxfordjournals.org Heart failure (HF) is a major international public health problem that is becoming epidemic as the population ages. 1 Despite advances in treating HF in ambulatory patients, acute cardiac decompensation and failure remain associated with high rates of morbidity and death. 1 ... Related articles - All 2 versions
V Piacentino III, ML Williams, T Depp… - The Annals of thoracic …, 2011 - Elsevier ... Hospital records were reviewed to determine the duration of postimplant intravenous inotropic agent support, need for temporary RV assist device (RVAD), and length of hospital stay. Inotropic agents used after implant included dopamine, dobutamine, and milrinone. ... Cited by 1 - Related articles - All 4 versions
DA Wink, M Feelisch, DA Kass, N Paolocci… - US Patent …, 2011 - Google Patents ... Additionally, in contrast to the effects observed with NO" donors, administration of an HNO/NO" donor in combination with a positive inotropicagent did not impair the positive inotropic effect of the posi- tive inotropicagent. Further ... Related articles - All 3 versions
CM Baker‐Smith, SR Neish… - Congenital heart …, 2011 - Wiley Online Library ... Type and Duration of Vasoactive/InotropicAgent Use. ... HLHS, hypoplastic left heart syndrome; ICU, intensive care unit. image. Variation in Postoperative Vasoactive and InotropicAgent Use. A number of vasoactive and inotropic agents were prescribed. ... Related articles - All 3 versions
G Hasenfuss… - European Heart Journal, 2011 - Eur Soc Cardiology ... Istaroxime—a new luso-inotropicagent? ... Therefore, additional effects on top of Na + /K + -ATPase inhibition, which promote calcium uptake of the SR, may be crucial to the potential success of this type of inotropicagent. In a study of guinea pig myocytes, Micheletti et al. ... Cited by 4 - Related articles - All 2 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
